Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: A randomized trial

David R. Anderson, Michael J. Dunbar, Eric R. Bohm, Etienne Belzile, Susan R. Kahn, David Zukor, William Fisher, Wade Gofton, Peter Gross, Stephane Pelet, Mark Crowther, Steven Macdonald, Paul Kim, Susan Pleasance, Nicki Davis, Pantelis Andreou, Philip Wells, Michael Kovacs, Marc A. Rodger, Tim RamsayMarc Carrier, Pascal Andre Vendittoli

Research output: Contribution to journalArticlepeer-review

141 Scopus citations

Fingerprint

Dive into the research topics of 'Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: A randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences